MXPA06014648A - Formulaciones topicas para tratar pacedimientos alergicos. - Google Patents
Formulaciones topicas para tratar pacedimientos alergicos.Info
- Publication number
- MXPA06014648A MXPA06014648A MXPA06014648A MXPA06014648A MXPA06014648A MX PA06014648 A MXPA06014648 A MX PA06014648A MX PA06014648 A MXPA06014648 A MX PA06014648A MX PA06014648 A MXPA06014648 A MX PA06014648A MX PA06014648 A MXPA06014648 A MX PA06014648A
- Authority
- MX
- Mexico
- Prior art keywords
- alkyl
- mmol
- oxepin
- nr6r7
- nhc
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58338004P | 2004-06-28 | 2004-06-28 | |
| PCT/US2005/022940 WO2006004757A2 (en) | 2004-06-28 | 2005-06-27 | Topical formulations for treating allergic diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA06014648A true MXPA06014648A (es) | 2007-02-12 |
Family
ID=35502431
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA06014648A MXPA06014648A (es) | 2004-06-28 | 2005-06-27 | Formulaciones topicas para tratar pacedimientos alergicos. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20050288283A1 (https=) |
| EP (1) | EP1761259A2 (https=) |
| JP (1) | JP2008504300A (https=) |
| KR (1) | KR20070024618A (https=) |
| CN (1) | CN1976694A (https=) |
| AU (1) | AU2005259911A1 (https=) |
| BR (1) | BRPI0512732A (https=) |
| CA (1) | CA2569519A1 (https=) |
| MX (1) | MXPA06014648A (https=) |
| WO (1) | WO2006004757A2 (https=) |
| ZA (1) | ZA200610350B (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005102313A1 (ja) * | 2004-04-21 | 2005-11-03 | Kyowa Hakko Kogyo Co., Ltd. | 慢性副鼻腔炎の予防および／または治療剤 |
| US20060111436A1 (en) * | 2004-11-23 | 2006-05-25 | John Griffin | Compositions and treatments for modulating kinase and/or HMG-CoA reductase |
| CA2664345A1 (en) * | 2006-09-29 | 2008-04-03 | Nippon Zoki Pharmaceutical Co., Ltd. | Oxepin derivative |
| WO2010089268A2 (en) * | 2009-02-05 | 2010-08-12 | Zach System S.P.A. | Process for preparing olopatadine and/or a pharmaceutically acceptable salt thereof |
| WO2014026611A1 (en) * | 2012-08-14 | 2014-02-20 | Huawei Technologies Co., Ltd. | Rollback method and apparatus of transaction, relational database management system |
| CN106117176B (zh) * | 2016-06-24 | 2018-12-11 | 四川大学 | 二氢双苯并恶庚衍生物及其组合物与应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4923892A (en) * | 1985-08-17 | 1990-05-08 | Burroughs Wellcome Co. | Tricyclic aromatic compounds |
| GB8520662D0 (en) * | 1985-08-17 | 1985-09-25 | Wellcome Found | Tricyclic aromatic compounds |
| JPS6310784A (ja) * | 1986-03-03 | 1988-01-18 | Kyowa Hakko Kogyo Co Ltd | 抗アレルギー剤 |
| US5641805A (en) * | 1995-06-06 | 1997-06-24 | Alcon Laboratories, Inc. | Topical ophthalmic formulations for treating allergic eye diseases |
| AU5722701A (en) * | 2000-05-19 | 2001-12-03 | Alcon Universal Ltd | Aniline disulfide derivatives for treating allergic diseases |
| JP2003534274A (ja) * | 2000-05-19 | 2003-11-18 | アルコン，インコーポレイテッド | アレルギー性疾患を処置するための、ベンズアミドジスルフィド誘導体を含む組成物 |
| DK1282599T3 (da) * | 2000-05-19 | 2006-07-31 | Alcon Inc | Disulfidderivater, der er egnede til behandling af allergiske sygdomme |
| TWI231759B (en) * | 2001-06-27 | 2005-05-01 | Alcon Inc | Olopatadine formulations for topical administration |
-
2005
- 2005-06-27 BR BRPI0512732-7A patent/BRPI0512732A/pt not_active IP Right Cessation
- 2005-06-27 EP EP05766591A patent/EP1761259A2/en not_active Withdrawn
- 2005-06-27 WO PCT/US2005/022940 patent/WO2006004757A2/en not_active Ceased
- 2005-06-27 US US11/167,634 patent/US20050288283A1/en not_active Abandoned
- 2005-06-27 CA CA002569519A patent/CA2569519A1/en not_active Abandoned
- 2005-06-27 ZA ZA200610350A patent/ZA200610350B/xx unknown
- 2005-06-27 CN CNA2005800213736A patent/CN1976694A/zh active Pending
- 2005-06-27 MX MXPA06014648A patent/MXPA06014648A/es unknown
- 2005-06-27 KR KR1020067026806A patent/KR20070024618A/ko not_active Withdrawn
- 2005-06-27 JP JP2007518371A patent/JP2008504300A/ja not_active Withdrawn
- 2005-06-27 AU AU2005259911A patent/AU2005259911A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN1976694A (zh) | 2007-06-06 |
| US20050288283A1 (en) | 2005-12-29 |
| AU2005259911A1 (en) | 2006-01-12 |
| WO2006004757A2 (en) | 2006-01-12 |
| WO2006004757A3 (en) | 2006-03-09 |
| BRPI0512732A (pt) | 2008-04-08 |
| EP1761259A2 (en) | 2007-03-14 |
| CA2569519A1 (en) | 2006-01-12 |
| JP2008504300A (ja) | 2008-02-14 |
| KR20070024618A (ko) | 2007-03-02 |
| ZA200610350B (en) | 2008-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2002012189A1 (en) | Fused bicyclic amide compounds and medicinal use thereof | |
| JP2010024243A (ja) | 緑内障および近視を処置するためのベンゾ［ｇ］キノリン誘導体 | |
| EP0539503B1 (en) | Excitatory amino acid antagonists | |
| JP2010095550A (ja) | キノリン誘導体 | |
| JP2001505198A (ja) | Ｐｄｅ阻害剤としての置換ジヒドロベンゾフラン | |
| DE69321609T2 (de) | Piperazinderivate | |
| MXPA06014648A (es) | Formulaciones topicas para tratar pacedimientos alergicos. | |
| JP2007297283A (ja) | 新規桂皮酸関連化合物 | |
| DE69126814T2 (de) | Substituierte aromatische Sulfonamide als Mittel gegen Glaukom | |
| WO2010010935A1 (ja) | 光学活性なヘテロシクリデン－ｎ－アリールアセトアミド誘導体 | |
| CA2332505A1 (en) | Serotonergic 5ht7 receptor compounds for treating ocular and cns disorders | |
| DE69605975T2 (de) | Arylalkyl(thio)carboxamidverbindungen mit Affinität für Melatoninrezeptoren, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen | |
| WO1993012080A1 (en) | Substituted diphenylsulfides as serotonin uptake inhibitors | |
| CN1113872C (zh) | 三环苯并[e]异吲哚和苯并[h]异喹啉 | |
| US2652399A (en) | Tertiary-aminoalkyl derivatives of coumarilic acids and their preparation | |
| CA1243326A (en) | Dibenz¬be|oxepinacetic acid derivatives, the preparation thereof and their application in therapy | |
| DE60204668T2 (de) | Piperazinderivate und deren verwendung als 5-ht1b liganden | |
| JPH03184943A (ja) | 脳血管剤として有用な多環式アミン | |
| US6407093B1 (en) | 1,4-Diazacycloheptane derivatives for the treatment of neurological disorders | |
| WO2000040574A1 (en) | 1,4-diazacycloheptane compounds, process for their preparation, and their use as medicaments | |
| JPS58162590A (ja) | 五員環化合物 | |
| TAKE et al. | Agents for the treatment of overactive detrusor. III. Synthesis and structure-activity relationships of N-(4-amino-2-butynyl) acetamide derivatives | |
| US4681878A (en) | Fluoropheno-thiazine and pharmaceutical use | |
| JP2003502411A (ja) | 神経保護剤としての１，４−ジアザシクロヘプタン誘導体 | |
| JP2002533447A (ja) | 神経疾患の治療に有用な１，４−ジアザシクロヘプタン誘導体 |